In annual report, EMA welcomes progress toward post-Brexit relocation

Europe’s pharmaceutical regulator the European Medicines Agency (EMA) has published its 2017 annual report highlighting the group’s major achievements and the key events of the previous year.

Executive director Guido Rasi expressed his agency's  contentment with the decision to relocate the EMA from London to Amsterdam, a consequence of the UK choosing to leave the European Union, saying the choice of city “came as a welcome relief,” due to the fact that “the city ticks many of our boxes.”

He added: “We have been working closely with the network to ensure that the resources and capacity required are available to guarantee an orderly redistribution of the work currently undertaken by the UK."